ABC | Volume 113, Nº3, Setembro 2019

Atualização Atualização da Diretriz de Ressuscitação Cardiopulmonar e Cuidados Cardiovasculares de Emergência da Sociedade Brasileira de Cardiologia – 2019 Arq Bras Cardiol. 2019; 113(3):449-663 623. Marler J, National Institute of Neurological Disorders and Stroke. Rapid identification and treatment of acute stroke. Proceedings of a National Symposium on Rapid Identification and Treatment of Acute Stroke. Bethesda: National Institute of Neurological Disorders and Stroke; 1997. 624. Mitchell JB, BallardDJ,Whisnant JP, Ammering CJ, Samsa GP, Matchar DB. What role do neurologists play in determining the costs and outcomes of stroke patients? Stroke. 1996;27(11):1937-43. 625. Ronning OM, Guldvog B. Should stroke victims routinely receive supplemental oxygen? A quasi-randomized controlled trial. Stroke. 1999;30(10):2033-7. 626. Bhalla A, Sankaralingam S, Dundas R, Swaminathan R, Wolfe CD, Rudd AG. Influence of raised plasma osmolality on clinical outcome after acute stroke. Stroke. 2000;31(9):2043-8. 627. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, et al. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke. 2008;39(2):384-9. 628. Huang Y, Sharma VK, Robinson T, Lindley RI, Chen X, Kim JS, et al. Rationale, design, and progress of the ENhanced Control of Hypertension ANd Thrombolysis strokE stuDy (ENCHANTED) trial: An international multicenter 2?×?2 quasi-factorial randomized controlled trial of low vs. standard-dose rt-PA and early intensive vs. guideline recommended blood pressure lowering in patients with acute ischaemic stroke eligible for thrombolysis treatment. Int J Stroke. 2015;10(5):778-8. 629. SpriggN,GrayLJ,BathPM,BoysenG,DeDeynPP,FriisP,etal.Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens. 2006;24(7):1413-7. 630. Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR; GAIN International Steering Committee and Investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial. Stroke. 2003;34(10):2420-5. 631. Leonardi-Bee J, Bath PM, Phillips SJ, , Sandercock PA; IST Collaborative Group. Blood pressure and clinical outcomes in the International Stroke Trial. Stroke. 2002;33(5):1315-20. 632. Azzimondi G, Bassein L, Nonino F, Fiorani L, Vignatelli L, Re G, et al. Fever in acute stroke worsens prognosis: a prospective study. Stroke. 1995;26(11):2040-3. 633. Sandercock PAG, Counsell C, Kane EJ. Anticoagulants for acute ischaemic stroke. Cochrane Database of Syst Rev. 2015 Mar 12;(3):CD000024. 634. Wong KS, Chen C, Ng PW, Tsoi TH, Li HL, FongWC, et al. Low-molecular- weight heparin comparedwith aspirin for the treatment of acute ischaemic stroke in Asian patients with large artery occlusive disease: a randomised study. Lancet Neurol. 2007;6(5):407-13. 635. CAST (ChineseAcuteStrokeTrial)CollaborativeGroup.CAST:randomised placebo-controlled trial of early aspirin use in 20.000 patients with acute ischaemic stroke. Lancet. 1997;349(9066):1641-9. 636. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569-81. 637. Johnston SC, Amarenco P, Albers GW, Denison H, Easton D, Evans SR, et al. Ticagrelor versus Aspirin in Acute Stroke or Transient Ischemic Attack. N Engl J Med. 2016;375(1):35-43. 638. Zhang Q, Wang C, Zheng M, Li Y, Li J, Zhang L, et al. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis. Cerebrovasc Dis. 2015;39(1):13-22. 639. Amarenco P, Bogousslavsky J, Callahan A 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med. 2006;355(6):549-59. 640. Kennedy J, Hill MD, Ryckborst KJ, EliasziwM, Demchuk AM, Buchan AM, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007;6(11):961-9. 641. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363(9411):768-74. 642. Multicenter Acute Stroke Trial--Europe Study Group, Hommel M, Cornu C, Boutitie F, Boissel JP. Thrombolytic therapy with streptokinase in acute ischemic stroke. N Engl J Med. 1996;335(3):145-50. 643. Brasil. Ministério da Saúde. Portaria 664 de 12 de abril de 2012. Diario Oficial da União 13 abr 2012;72:33-5. 644. Demaerschalk BM, Kleindorfer DO, Adeoye OM, Demchuk AM, Fugate JE, Grotta JC, et al. Scientific Rationale for the Inclusion and Exclusion Criteria for IntravenousAlteplase inAcute IschemicStroke:AStatement for Healthcare Professionals From the AmericanHeart Association/American Stroke Association. Stroke. 2016;47(2):581-641. 645. Pincus MM. Consent issues in the management of cerebrovascular diseases: a position paper of the American Academy of Neurology Ethics and Humanities Subcommittee. Neurology. 1999;53(1)1:9-11. 646. Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokEDOC trial: a randomised, blinded, prospective study. Lancet Neurol. 2008;7(9):787-95. 647. Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemio-rolingual angioedema and ace inhibition after alteplase treatment of stroke. Neurology. 2003;60(9):1525-7. 648. Furlan A, Higashida R,Wechsler L, , Gent M, RowleyH, Kase C,et al. Intra- arterial prourokinase for acute ischemic stroke: The PROACT II Study: a randomized controlled trial. JAMA. 1999;282(21):2003-11. 649. MattleHP, ArnoldM, Georgiadis D, Baumann C, Nedeltchev K, Benninger D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke. 2008;39(2):379-83. 650. Nedeltchev K, Fischer U, Arnold M. Ballinari P, Haefeli T, Kappeler L, et al. Long-term effect of intra-arterial thrombolysis in stroke. Stroke. 2006;37(12):3002-7. 651. Macleod MR, Davis SM, Mitchell PJ, Gerraty RP, Fitt G, Hankey GJ, et al. Results of a multicentre, randomised controlled trial of intra-arterial urokinase in the treatment of acute posterior circulation ischaemic stroke. Cerebrovasc Dis. 2005;20(1):12-17. 652. Broderick JP, Palesch YY, Demchuk AM, Yeatts SD, Khatri P, Hill MD, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013;368(10):893-903. 653. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008;39(4):1205-12. 654. Berkhemer OA, Fransen PS, Beumer D, van den Berg LA, Lingsma HF, Yoo AJ, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20. 655. Campbell BC, Mitchell PJ, Kleinig TJ, Dewey HM, Churilov L, Yassi N, et al. Endovasculartherapy for ischemicstrokewithperfusion-imagingselection. N Engl J Med. 2015;372(11):1009-18. 656. Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-30. 657. Saver JL, Goyal M, Bonafe A, Diener HC, Levy EI, Pereira VM, et al. Stent- retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-95. 643